| Literature DB >> 35056751 |
Lihu Zhang1,2, Chunyi Zhu1, Xiaoqing Liu1, Erzheng Su3, Fuliang Cao4, Linguo Zhao1,4.
Abstract
The predicted anti-oxidation is related to apoptosis, proliferation, lipid metabolism, cell differentiation, and immune response. There are some differences in the antioxidant capacity of the four typical components of ginkgo biloba extract (EGb) including ginkgo flavone (GF), ginkgolide (G), procyanidins (OPC), and organic acids (OA), and any two members of them can exhibit apparent synergistic effects. The order of DPPH scavenging ability was: OPC > GF > OA > G. The scavenging ability of procyanidins was close to that of VC; the scavenging capacity of ABTS was GF > OPC > OA > G. The GF:OPC (1:9) showed the best synergism in scavenging DPPH and ABTS radicals. The 193 kinds of small molecules reported in EGb were obtained by analyzing the properties of EGb. In order to construct a corresponding biological activity target set, molecular docking and the network pharmacology method were employed to build the molecular action mechanism network of a compound target, and the main biological functions and signaling pathways involved with their antioxidant activities were predicted. The results displayed that the top ten compounds which belonged to the two broad categories, ginkgo flavonoids and proanthocyanidins, could interact closely with several important target proteins (CASP3, SOD2, MAPK1, HSPA4, and NQO1). This would be expected to lay a theoretical foundation for the deep development of Ginkgo biloba extract.Entities:
Keywords: Ginkgo biloba extract (EGb); antioxidation; ginkgo flavone; ginkgolide; synergism
Mesh:
Substances:
Year: 2022 PMID: 35056751 PMCID: PMC8778188 DOI: 10.3390/molecules27020439
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
The IC50 value of DPPH radical scavenging from each functional component of EGb. (Ginkgo biloba extract (EGb), ginkgo flavone (GF), ginkgolide (G), procyanidins (OPC), and organic acids (OA)).
| Component | EGb | GF | G | OPC | OA | VC |
|---|---|---|---|---|---|---|
| IC50 (μg/mL) | 47.82 ± 1.05 | 19.56 ± 0.763 | 672.2 ± 0.627 | 4.009 ± 0.358 | 40.40 ± 1.16 | 5.725 ± 0.612 |
Figure 1Scavenging effects of EGb functional components on DPPH free radicals.
Synergistic effect of functional components of EGb scavenging DPPH free radical.
| Type of Compound | Proportion | The IC50 Value of DPPH Scavenging Effect of Compound (μg/mL) | ||
|---|---|---|---|---|
| Theoretical IC50 Value | Measured IC50 Value | γ | ||
| G + GF | 9:1 | 155.01 | 139.0 | 0.90 |
| 7:3 | 61.05 | 104.5 | 1.71 | |
| 1:1 | 38.01 | 77.73 | 2.04 | |
| 3:7 | 27.60 | 40.42 | 1.46 | |
| 1:9 | 21.66 | 53.06 | 2.45 | |
| OPC + GF | 9:1 | 18.84 | 14.37 | 3.30 |
| 7:3 | 9.04 | 12.85 | 2.44 | |
| 1:1 | 6.65 | 14.26 | 2.14 | |
| 3:7 | 5.26 | 13.34 | 1.48 | |
| 1:9 | 4.36 | 7.095 | 0.50 | |
| OA + GF | 9:1 | 20.37 | 47.86 | 2.32 |
| 7:3 | 23.14 | 41.4 | 1.79 | |
| 1:1 | 26.36 | 36.25 | 1.38 | |
| 3:7 | 30.61 | 29.78 | 0.97 | |
| 1:9 | 36.51 | 28.25 | 0.77 | |
| G + OPC | 9:1 | 38.05 | 152.62 | 4.01 |
| 7:3 | 13.18 | 39.57 | 3.00 | |
| 1:1 | 7.97 | 26.15 | 3.28 | |
| 3:7 | 5.71 | 16.86 | 2.95 | |
| 1:9 | 4.45 | 9.66 | 2.17 | |
| OA + G | 9:1 | 262.18 | 37.64 | 0.84 |
| 7:3 | 118.10 | 45.74 | 0.81 | |
| 1:1 | 76.22 | 67.83 | 0.89 | |
| 3:7 | 56.27 | 74.46 | 0.63 | |
| 1:9 | 44.59 | 237.5 | 0.91 | |
Figure 2Scavenging effect of EGb functional components on ABTS free radicals.
The IC50 value of ABTS radical scavenging from each functional component of EGb.
| Components | EGb | GF | G | OPC | OA | VC |
|---|---|---|---|---|---|---|
| IC50 (μg/mL) | 204.4 ± 0.137 | 24.25 ± 1.70 | 377.6 ± 0.402 | 69.44 ± 1.433 | 101.8 ± 0.594 | 6.414 ± 2.07 |
Synergistic effect of functional components of EGb scavenging ABTS free radical.
| Type of Compound | Proportion | The IC50 Value of ABTS Scavenging Effect of Compound (μg/mL) | ||
|---|---|---|---|---|
| Theoretical IC50 Value | Measured IC50 Value | γ | ||
| G + GF | 9:1 | 58.53 | 140.12 | 0.91 |
| 7:3 | 44.54 | 75.56 | 1.07 | |
| 1:1 | 35.95 | 56.32 | 1.24 | |
| 3:7 | 30.13 | 42.07 | 1.25 | |
| 1:9 | 25.94 | 36.02 | 1.35 | |
| OPC + GF | 9:1 | 58.53 | 74.33 | 1.27 |
| 7:3 | 44.54 | 42.81 | 0.96 | |
| 1:1 | 35.95 | 24.26 | 0.67 | |
| 3:7 | 30.13 | 16.36 | 0.54 | |
| 1:9 | 25.94 | 10.01 | 0.39 | |
| OA + GF | 9:1 | 77.13 | 87.56 | 3.34 |
| 7:3 | 51.96 | 51.42 | 1.64 | |
| 1:1 | 39.17 | 46.25 | 1.18 | |
| 3:7 | 31.43 | 49.71 | 0.96 | |
| 1:9 | 26.25 | 31.65 | 0.41 | |
| G + OPC | 9:1 | 261.54 | 256.62 | 0.98 |
| 7:3 | 161.97 | 209.51 | 1.29 | |
| 1:1 | 117.31 | 126.15 | 1.08 | |
| 3:7 | 91.95 | 104.86 | 1.14 | |
| 1:9 | 75.61 | 89.66 | 1.19 | |
| OA + G | 9:1 | 71.72 | 127.67 | 1.16 |
| 7:3 | 76.76 | 155.46 | 1.19 | |
| 1:1 | 82.56 | 148.23 | 0.92 | |
| 3:7 | 89.31 | 231.46 | 1.11 | |
| 1:9 | 97.27 | 337.5 | 1.14 | |
Molecular descriptors of compounds contained by EGb.
| Molecular Descriptors | Minimum Value | Maximum Value | Average Value | Median Value |
|---|---|---|---|---|
| Lipid/water partition coefficient (AlogP) | −2.74 | 12.95 | 3.26 | 2.77 |
| Relative molecular mass | 84.12 | 668.60 | 424.40 | 212.29 |
| Number of hydrogen bond receptors | 0 | 17.00 | 3.54 | 1.00 |
| Number of hydrogen bond donors | 0 | 10.00 | 1.88 | 1.00 |
| Number of rotatable keys | 0 | 28.00 | 4.56 | 2.00 |
| Molar refractive index | 23.15 | 193.62 | 73.15 | 68.01 |
| Number of molecular aromatic rings | 0 | 1.00 | 6.00 | 1.96 |
| Molecular polar surface area ratio (Polar) | 0 | 269.43 | 64.97 | 29.46 |
| Number of heavy atoms | 6.00 | 47.00 | 19.27 | 16.00 |
| Number of chiral centers | 0 | 14.00 | 1.90 | 0 |
Figure 3Principal component analysis of the physical and chemical properties of the 193 small molecules belonging to EGb.
Known potential proteins as the antioxidant targets.
| Target Protein | Full Name | PDB ID [ |
|---|---|---|
| CAT | Catalase | 1DGH |
| SOD1 | Superoxide dismutase 1 | 2WZ0 |
| GSR | Glutathione reductase | 2GH5 |
| HMOX1 | Heme oxygenase 1 | 3TGM |
| SOD2 | Superoxide dismutase 2 | 4A7V |
| LPA1 | Lysophosphatidic acid receptor 1 | 4Z34 |
| GSTK1 | Glutathione S-transferase kappa 1 | 3RPN |
| ALB | Serum albumin | 4Z69 |
| AChE | Acetylcholinesterase | 5HFA |
| Caspase-3 | Caspase-3 | 3KJF |
| BCL2 | Bcl-2-like protein 1 | 4QVX |
| MPO | Myeloperoxidase | 4C1M |
| KEAP1 | Kelch-like ECH-associated protein 1 | 5DAF |
| MAPK1 | Mitogen-activated protein kinase 1 | 4QTE |
| AKT1 | Threonine-protein kinase | 5KCV |
| NQO1 | NAD(P)H dehydrogenase 1 | 2F1O |
| G6PD | Glucose-6-phosphate 1-dehydrogenase | 2BH9 |
| NOS | Nitric oxide synthase | 3HR4 |
| E3Mdm2 | E3 ubiquitin-protein ligase Mdm2 | 5HMK |
| MTOR | Phosphatidylinositol-4,5-bisphosphate-3-kinase catalytic subunit gamma isoform | 3PRE |
| PTGS2 | Prostaglandin G/H synthase 2 | 5IKT |
| MAPK8 | Mitogen-activated protein kinase 8 | 4QTD |
| PRDX5 | Peroxiredoxin-5 | 4MMM |
| TXN | Thioredoxin | 5DQY |
| HSPA1 | Heat shock 70 kDa protein 1 | 1S3X |
| MAPK14 | Mitogen-activated protein kinase 14 | 4ZTH |
| GCLC | Glycogenin-1 | 3U2V |
Figure 4Network chart of compound-target protein in compounds in EGb.
Network features of part nodes in the D-T network in EGb.
| Node | Betweenness | Network Degree | Node | Betweenness | Network Degree |
|---|---|---|---|---|---|
| ALB | 0.41420 | 113 | Epicatechin | 0.0091845 | 16 |
| SOD2 | 0.15260 | 69 | Quercetin | 0.0085938 | 15 |
| MAPK1 | 0.074029 | 62 | Epigallocatechin | 0.0084424 | 15 |
| HSPA4 | 0.052319 | 59 | 6-HKA | 0.0094497 | 14 |
| NQO1 | 0.065040 | 59 | Apigenin | 0.0089222 | 14 |
| G6PD | 0.044772 | 56 | Ginkgolin | 0.0093173 | 14 |
| GSTK1 | 0.041743 | 53 | Myricetin | 0.0069732 | 14 |
| KEAP1 | 0.041642 | 47 | Isorhamnetin | 0.0068786 | 14 |
| CAT | 0.043828 | 47 | Catechin | 0.0063781 | 14 |
Figure 5Molecular function and metabolic pathway analysis of EGb. (A) “Targets-Pathway-Disease” network of EGb; (B) Gene percent involved with these pathways and diseases; (C) Six primary pathways related with antioxidation; (D) Eight antioxidant mechanisms of EGb. ** Indicates that the p-value is less than 0.01.
Figure 6Isoradiation analysis of drugs A and B.